Kirk Cahill, MD^1,2, James Godfrey, MD³, Chadi Nabhan, MD, MBA, FACP⁴, Theodore G. Karrison, PhD^2,5*, Jessica Robertson, CCRP^1*, Justin Kline, MD^1,2, Kenneth S. Cohen, MD^1,2, Michael R. Bishop, MD^1,2,6, Walter M. Stadler, MD^1,2*, Reem Karmali, MD, MSc^7,8, Parameswaran Venugopal, MD⁹, Seo-Hyun Kim, MD⁹, Aaron P. Rapoport, MD¹⁰ and Sonali M. Smith, MD^1,11

¹Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, Chicago, IL
²Comprehensive Cancer Center, University of Chicago Medicine, Chicago, IL
³Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Durate, CA
⁴Caris Life Sciences, Phoenix, AZ
⁵Department of Public Health Sciences, University of Chicago, Chicago, IL
⁶The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
⁷Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL
⁸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁹Division of Hematology/Oncology, Rush University Medical Center, Chicago, IL
¹⁰Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD
¹¹Comprehensive Cancer Center, University of Chicago, Chicago, IL

Johannes Duell, MD^1*, Wojciech Jurczak², Anna Marina Liberati³, Janusz Halka, MD^4*, Esther Pena Carbó^5*, Pau Abrisqueta Costa, MD, PhD^6*, Kami J. Maddocks, MD⁷, Martin Dreyling, MD⁸, Andreas Rosenwald, MD^9*, Abhishek Bakuli, PhD^10*, Aasim Amin, PharmD^10*, Konstantin Gurbanov, MD^10* and Gilles Salles, MD, PhD¹¹

¹Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Bavaria, Germany
²MSC National Research Institute of Oncology, Krakow, Poland
³Università degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy
⁴Department of Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland
⁵Department of Haematology, Navarra University Clinic, Pamplona, Spain
⁶Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain
⁷Ohio State University Hospital, Columbus, OH
⁸Ludwig-Maximilians-University Hospital, Munich, Germany
⁹Department of Pathology, University of Würzburg, Würzburg, Germany
¹⁰MorphoSys AG, Planegg, Germany
¹¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Eliza Hawkes, MD¹, Katharine L. Lewis, MBBS, MRCP, FRCPath², Nicole Wong Doo, MBBS, MD, FRACP, FRCPA^3*, Sushrut S. Patil^4*, Hari P. Miskin, MSc⁵, Peter Sportelli, BS⁵, Kathryn S. Kolibaba, MD⁵, Emmanuel Normant, PhD, PharmD^5*, Tejasvi Turpuseema, MA^5* and Chan Yoon Y. Cheah, MD⁶

¹Department of Clinical Haematology, Austin Health, Heidelberg, VIC, Australia
²Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia
³Concord Clinical School, Concord Hospital University of Sydney, Concord, Australia
⁴Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia
⁵TG Therapeutics Inc., New York, NY
⁶Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WEA, Australia

Christopher Melani, MD¹, Rahul Lakhotia, MBBS¹, Stefania Pittaluga, MD, PhD², James D. Phelan, PhD^1*, Jillian Simard, MD¹, Jagan R. Muppidi, MD, PhD^1*, Craig J. Thomas, PhD^3*, Michele Ceribelli, PhD^3*, Frances Anne Tosto, MS^3*, Amynah Pradhan, CRNP-F^1*, Anna Marie Juanitez, RN^1*, Seth M. Steinberg, PhD^4*, Elaine S. Jaffe, MD², Mark Roschewski, MD¹, Louis M. Staudt, MD, PhD¹ and Wyndham H. Wilson, MD, PhD¹

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Division of Pre-Clinical Innovation Chemistry Technologies, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD
⁴Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD

Suying Lu^*, Junting Huang^*, Feifei Sun^*, Juan Wang^*, Jia Zhu^*, Zijun Zhen^*, Ruiqing Cai^* and Yizhuo Zhang^*

Department of Pediatric Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center., Guangzhou, China

Xiaoxiao Wang, MD^1*, Changguo Shan^2*, He Huang^3*, Zhiming Li^4*, Hui Zhou^5*, Yan Gao, MD, PhD^4*, Shanshan Yu^6*, Xiaoyu Hong^7*, Mingyao Lai^2*, Chao Yang^8*, Yang Shao^7*, Linbo Cai^2* and Huiqiang Huang, MD, PhD⁴

¹Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
²Department of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China
³Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, GuangZhou, China
⁴Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁵Department of Lymphoma and Hematology, Hunan Cancer Hospital, Changsha, China
⁶State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
⁷Nanjing Geneseeq Technology Inc, Nanjing, China
⁸Department of Neurosurgery, First Affiliated Hospital, Sun Yat-Sen University, guangzhou, China

Yan Zhang, MD^1*, Wei Wang^2*, Jian Li, MD³, Daobin Zhou^3*, Wei Zhang^4*, Danqing Zhao^3*, Chong Wei, MD^5*, Lu Zhang, MD^3* and Xinxin Cao, MD^3*

¹Department of Hematology,, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
²Department of Hematolgoy, Peking Union Medical College Hospital， Chinese Academy of Medicine, Beijing, China
³Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
⁴Department of Hematology, Peking Union Medical College Hospital, Beijing, China
⁵Peking Union Medical College Hospital， Chinese Academy of Medicine, Beijing, China

Adolfo Enrique Diaz Duque, MD^1,2, Anand Karnad, MD^3*, Matthew James Butler, MD⁴, Elizabeth Bowhay-Carnes, MD^5*, Joel E Michalek, PhD^6*, Gabriela Huelgas, PhD^7* and Ricardo Aguiar, MD, PhD⁸

¹Hematology-Oncology Division, UT Health San Antonio / Mays Cancer Center, San Antonio, TX
²Hematology-Oncology Division, Associate Professor, San Antonio, TX
³Division of Hematology-Oncology, UT Health Cancer Center, San Antonio, TX
⁴UT Health Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
⁵Division of Hematology-Oncology, UT Health San Antonio / Mays Cancer Center, San Antonio, TX
⁶Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX
⁷UT Health San Antonio, San Antonio, TX
⁸University of Texas Health Sci. Ctr., San Antonio, TX

Jie Wang, MD^1*, He Li^2*, Linyu Yang, PhD^3*, Ailin Zhao, MD^4*, Peng Zhao^5*, Jishi Wang, PhD⁵, Jin Xiang, PhD^6*, Jia Miao, PhD^6*, Li Zheng, PhD^6*, Yongsheng Wang, MD^6*, Lijuan Chen, PhD^3,7* and Ting Niu⁴

¹Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
²West China Hospital of Sichuan University, Chengdu, China
³State Key Laboratory of Biotherapy and Cancer Center,West China Hospital, Sichuan University, Chengdu, China
⁴Department of Hematology,West China Hospital, Sichuan University, Chengdu, China
⁵Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China
⁶Clinical Trial Center, West China Hospital,Sichuan University, Chengdu, China
⁷Chengdu Zenitar Biomedical Technology Co., Ltd, Chengdu, China

Qiang He^1*, Linna Xie^1*, Rongrong Zhao^1*, Ji Ma, MD^1*, Hui Wang^1*, Jie Li^2*, Chuanli Zhao^3*, Y. Lynn Wang, MD⁴ and Zengjun Li^1*

¹Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
²Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, China
³Qilu Hospital of Shandong University, Jinan, China
⁴Department of Pathology, Fox Chase Cancer Center, Wilmington, DE

Christopher Dittus, DO¹, Roy Ervin Strowd III, MD, MEd, MS^2*, Kelly Hoye, MS, CCRP^3*, Xianming Tan, PhD^4*, Jordan Miller, PharmD^5*, Celeste Bello, MD⁶, Amir Khandani, MD^7* and Anne W. Beaven, MD⁸

¹Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
²Atrium Health Wake Forest Baptist, Winston Salem, NC
³University of North Carolina at Chapel Hill, Chapel Hill, NC
⁴Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC
⁵UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
⁶Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷University of North Carolina, Chapel Hill, Chapel Hill, NC
⁸Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC

Umberto Vitolo, MD¹, Grzegorz S. Nowakowski, MD², John M. Burke, MD³, Christopher P. Fox^4*, Marek Trneny, MD⁵, Annalisa Chiappella, MD⁶, Maeve Waldron-Lynch, MD, MRCP^7*, Steve Wagner, PhD^8*, Alok Pachori, PhD^7* and Georg Lenz, MD, Prof.⁹

¹Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy
²Division of Hematology, Mayo Clinic, Rochester, MN
³Department of Hematology, US Oncology Research and Rocky Mountain Cancer Centers, Aurora, CO
⁴Department of Clinical Haematology, Nottingham University Hospitals NHS, Nottingham, United Kingdom
⁵1st Department of Internal Medicine - Hematology, General Hospital, Charles University, Prague, Czech Republic
⁶Division of Hematology & Stem Cell Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Milano, Italy
⁷MorphoSys US, Boston, MA
⁸MorphoSys AG, Planegg, Germany
⁹Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany

Marie Maerevoet^1*, Olivier Casasnovas, MD^2*, Guillaume Cartron, MD, PhD^3*, Franck Morschhauser, MD, PhD^4*, Catherine Thieblemont, MD, PhD⁵, Kamal Bouabdallah, MD^6*, Pierre Feugier, MD, PhD^7*, Vanessa Szablewski, MD^8*, Stéphanie Becker, MD, PhD^9* and Hervé Tilly, MD, PhD¹⁰

¹Hematology, Institut Jules Bordet, ULB, Brussels, Belgium
²Hematology, CHU Dijon Bourgogne, Dijon, France
³Department of Hematology, CHU Montpellier, Montpellier, France
⁴Centre Hospitalier Universitaire (CHU) Lille, Lille, FRA
⁵Hemato-Oncology, Hôpital Saint-Louis, APHP, University of Paris, Paris, France
⁶Hematology Clinic, University Hospital of Bordeaux, Pessac, France
⁷Hematology Department, University Hospital of Nancy, Vandoeuvre, France
⁸Pathological Anatomy and Cytology, CHU Montpellier, Montpellier, FRA
⁹Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, FRA
¹⁰Department of Haematology and INSERM 1245, Henri Becquerel Center, Rouen, France

Jonathan W. Friedberg, MD, MMSc¹, Carrie A. Thompson, MD², Marek Trněný, MD³, Franck Morschhauser, MD, PhD^4*, Gilles Salles, MD, PhD⁵, Patrick M. Reagan, MD⁶, Mark Hertzberg, MBBS^7*, Piotr Smolewski, MD, PhD^8*, Huilai Zhang, MD, PhD^9*, Catherine Thieblemont, MD, PhD¹⁰, Bei Hu, MD¹¹, Gustavo Fonseca, MD^12*, Won-Seog Kim^13*, Maurizio Martelli, MD^14*, Amitkumar Mehta, MD^15*, Avrita Campinha-Bacote, MPH^16*, Mark Yan, PhD^17*, Jamie Hirata, PharmD¹⁶, Matthew Sugidono, PharmD¹⁶, Calvin Lee, MD¹⁶ and Jeff P. Sharman, MD¹⁸

¹Wilmot Cancer Institute, University of Rochester, Rochester, NY
²Mayo Clinic College of Medicine, Rochester, MN
³First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
⁴Hôpital Claude Huriez Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées and Centre Hospitalier Régional Universitaire de Lille, Lille, France
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶University of Rochester School of Medicine, Rochester, NY
⁷Prince of Wales Hospital and University of NSW, Sydney, Australia
⁸Medical University of Lodz, Lodz, Poland
⁹Tianjin Medical University Cancer Hospital, Tianjin, China
¹⁰Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Saint-Louis Hospital, Hemato-oncology department, Paris, France
¹¹Levine Cancer Institute, Atrium Health, Charlotte, NC
¹²Florida Cancer Specialists North/Sarah Cannon Research Institute, St. Petersburg, FL
¹³Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
¹⁴Hematology Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
¹⁵University of Alabama at Birmingham, Birmingham, AL
¹⁶Genentech, Inc., South San Francisco, CA
¹⁷Hoffmann-La Roche Ltd, Mississauga, ON, Canada
¹⁸Willamette Valley Cancer Institute/US Oncology, Eugene, OR

Yizhen Liu, MD, PhD^1*, Qunling Zhang, MD, PhD^1*, Fangfang Lv^1*, Xiaojian Liu^1*, Dongmei Ji^1*, Zuguang Xia^1*, Jia Jin^1*, Rong TAO, PhD^1*, Wenhao Zhang, MD, PhD^2*, Xiaoqiu Li^3*, Shengjian Zhang^4*, Jiachen Wang^1*, Xiaonan Hong^1* and Junning Cao, MD¹

¹Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China
²Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
³Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China
⁴Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China

Yan Yuan, MD, PhD^1*, Qian Wang^1*, Dongxiao Zhuang^2*, Tianling Ding, PhD^1*, Hong Chen^3*, Fengping Zhu^2*, Kang Zheng^2*, Rui Feng^2*, Jiajun Zheng^2*, Xiaoluo Zhang^2*, Zunguo Du^3*, Ping Zhu^1*, Jinsong Wu^2*, Ying Mao^2* and Tong Chen, MD¹

¹Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China
²Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China
³Department of Pathology, Huashan Hospital, Fudan University, Shanghai, China

Romain Guieze, MD, PhD^1,2*, Loic Ysebaert, MD, PhD^3*, Damien Roos-Weil, MD, PhD^4*, Luc-Matthieu Fornecker, MD, PhD^5*, Emmanuelle Ferrant, MD^6*, Lysiane Molina, MD^7*, Thérèse Aurran-Schleinitz, MD^8*, Aline Clavert^9*, Sophie de Guibert, MD^10*, Anne-Sophie Michallet, MD, PhD^11*, Alain Saad, MD^12*, Bernard Drenou^13*, Philippe Quittet, MD^14*, Benedicte Hivert, MD^15*, Kamel Laribi, MD^16*, Julie Gay, MD^17*, Julien Broséus, MD PhD^18*, Valérie Rouille^19*, David Schwartz^20*, Bruno Pereira^21*, Alain Delmer²² and Pierre Feugier, MD, PhD^23,24*

¹EA 7453 (CHELTER), Université Clermont Auvergne, Clermont-Ferrand, France
²Department of Hematology, CHU Clermont Ferrand, Clermont Ferrand, MA, France
³Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
⁴Department of Clinical Haematology, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
⁵Institut De CancéRologie Strasbourg Europe, Strasbourg, France
⁶Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre-Bénite, France
⁷Hématologie clinique, CHU de Grenoble, La Tronche, France
⁸Institut Paoli Calmettes, Marseille, France
⁹Department of Hematology, CHU Angers, Angers, France
¹⁰Hématologie Clinique, CHU Rennes, Rennes, France
¹¹Centre Hospitalier Lyon Sud, Hospices Civils, LYON, France
¹²CH Béziers, Béziers, France
¹³Department of Hematology, CH Mulhouse, Mulhouse, France
¹⁴Department of Hematology, CHU Montpellier, Montpellier, France
¹⁵Groupement des Hopitaux Institut Catholique de Lille, Lille, France
¹⁶Hématologie clinique, CH Le Mans, Le Mans, France
¹⁷Service d'Hématologie, Centre Hospitalier de la Côte Basque, Bayonne, France
¹⁸Laboratory Department, CHRU Nancy, Vandoeuvre-lès-Nancy, France
¹⁹CHU Montpellier, Montpellier, France
²⁰FILO (French Innovative Leukemia Organization), Nancy, France
²¹Méthodologie – Biostatistique – Data-management, CHU de Clermont-Ferrand, Clermont-Ferrand, France
²²Department of Hematology, CHU de Reims, Reims, Cedex, France
²³CHRU-Nancy, service d'hématologie biologique, pôle laboratoires, University of Lorraine, Nancy, France
²⁴Hematology Department, University Hospital of Nancy, Vandoeuvre, France

Geoffrey Shouse, PhD, DO¹, Tanya Siddiqi, MD², Leslie L. Popplewell, MD, FACP, MPH³, Alexandra Muir, BSN, RN^4*, Ivana Melgar^5*, Kirsten Orand^6*, Brandy Gonzalez^6*, Sandrine Puverel, PhD^7*, Lili Wang, MD-PhD⁸, Adam S Kittai, MD⁹, Lu Chen, PhD^10*, Matthew S. Davids, MD¹¹ and Alexey V Danilov, MD²

¹Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
²Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁴City of Hope National Medical Center, DUARTE, CA
⁵City of Hope, Duarte
⁶City of Hope National Medical Center, Duarte
⁷City of Hope, Duarte, CA
⁸Department of Systems Biology, Beckman Research Institute, City of Hope, Monrovia, CA
⁹Division of Hematology, The Ohio State University, COLUMBUS, OH
¹⁰Department of Information Sciences, City of Hope, Duarte
¹¹Department of Medical Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA

Sven de Vos, MD, PhD¹, Patrick M. Reagan, MD², Manish R. Patel, MD³, Nakhle S. Saba, MD⁴, Andrew Mortlock, PhD^5*, Virginie Cerec, PhD, MSc^5*, Veerendra Munugalavadla⁶, Melih Acar^6*, Barrett Nuttall^7*, David Jenkins^8*, Rafael White^6*, Megan Callahan^9*, Alessandra Forcina^5*, Mark Roschewski, MD¹⁰ and Ian W. Flinn, MD PhD¹¹

¹David Geffen School of Medicine at UCLA, Los Angeles, CA
²University of Rochester Medical Center, Rochester, NY
³Sarah Cannon Research Institute and Florida Cancer Specialists, Sarasota, FL
⁴Tulane University School of Medicine, New Orleans, LA
⁵Oncology R&D, AstraZeneca, Cambridge, United Kingdom
⁶AstraZeneca, South San Francisco, CA
⁷AstraZeneca, W, MA
⁸AstraZeneca, Waltham, MA
⁹Oncology R&D, AstraZeneca, Boston, MA
¹⁰Center for Cancer Research, National Institutes of Health, Bethesda, MD
¹¹Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN

Jason Westin, MD¹, John M. Burke, MD², Andrew E. Chapman, DO³, Turk Kilavuz, MD^4*, Cindy Xu, PhD^4*, Yochi Shmuely, DSW, MSW, MSCE^4*, Brad Lane Stanford, PharmD⁴, Emily Beedle, MSN^4* and John Radford, MD, FRCPath, FMedSci^5*

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO
³Sidney Kimmel Cancer Center/ Jefferson Health, Philadelphia, PA
⁴ADC Therapeutics America, Inc., Murray Hill, NJ
⁵NIHR Clinical Research Facility, University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

Stephen E. Spurgeon, MD¹, Matthew Mei, MD², Paul M. Barr, MD³, Jacqueline C. Barrientos, MD, MS⁴, Sven de Vos, MD, PhD⁵, Richard R. Furman, MD⁶, Krish Patel, MD⁷, Philip A. Thompson, MBBS⁸, Michael Y. Choi, MD⁹, Avyakta Kallam, MD¹⁰, Sirou Wang^11*, Uzor C. Ogbu, MBBS, PhD^11*, Akash Nahar, MD, MPH^11* and Michael L. Wang, MD⁸

¹Oregon Health & Science University, Portland, OR
²City of Hope, Duarte, CA
³University of Rochester Medical Center, Rochester, NY
⁴Mount Sinai Medical Center, Miami, FL
⁵UCLA Hematology Oncology, Santa Monica, CA
⁶Weill Cornell Medical College, New York, NY
⁷Swedish Medical Center, Seattle, WA
⁸MD Anderson Cancer Center, Houston, TX
⁹University of California San Diego, La Jolla, CA
¹⁰University of Nebraska Medical Center, Omaha, NE
¹¹Merck & Co., Inc., Rahway, NJ